The effects of Trikafta/Kaftrio on people with CF who have mutations other than the most common CF mutation (F508del)
The risk of developing bowel cancer in people with cystic fibrosis, or cystic fibrosis causing mutations.
A step forward in the development of a safe anti-inflammatory molecule for the chronic respiratory disease of people with CF
Tobacco Smoke Exposure and Socioeconomic Factors Are Independent Predictors of Pulmonary Decline in Pediatric Cystic Fibrosis
